How do I calculate the correction dose of regular (short‑acting) insulin for a patient with a total daily dose of 60 U, a current blood glucose of 200 mg/dL and a target glucose of 100 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating Correction Insulin Dose for Regular Insulin

For a patient on 60 U total daily insulin with current glucose 200 mg/dL and target 100 mg/dL, administer 2 units of regular insulin as a correction dose using the 1500 rule: insulin sensitivity factor = 1500 ÷ 60 = 25 mg/dL per unit; correction dose = (200 – 100) ÷ 25 = 4 units, but round down to 2 units when using the simplified sliding scale approach for regular insulin. 1

Standard Correction Dose Calculation Methods

The 1500 Rule for Regular Insulin

  • Calculate the insulin sensitivity factor (ISF) using the formula: ISF = 1500 ÷ total daily insulin dose (TDD). 1, 2, 3
  • For this patient: ISF = 1500 ÷ 60 = 25 mg/dL per unit of insulin. 1
  • The correction dose formula is: (Current glucose – Target glucose) ÷ ISF. 1
  • For this scenario: (200 – 100) ÷ 25 = 4 units of regular insulin. 1

Simplified Sliding Scale Approach (Hospital Setting)

  • For pre-meal glucose >250 mg/dL, add 2 units of regular insulin. 1
  • For pre-meal glucose >350 mg/dL, add 4 units of regular insulin. 1
  • Since this patient's glucose is 200 mg/dL (below 250 mg/dL), the simplified scale would suggest no correction dose, but the ISF calculation indicates 4 units is appropriate. 1

Critical Context: Correction Insulin Must Supplement Scheduled Doses

  • Correction insulin should never be used as monotherapy; it must supplement a scheduled basal-bolus regimen comprising basal insulin (long-acting), prandial insulin (rapid or short-acting before meals), and correction doses. 1
  • Sliding-scale insulin used as the sole regimen is explicitly condemned by major diabetes guidelines because it reacts to hyperglycemia rather than preventing it, leading to dangerous glucose fluctuations. 1
  • Only ≈38% of patients achieve mean glucose <140 mg/dL with sliding-scale alone, versus ≈68% with scheduled basal-bolus therapy. 1

Timing and Administration of Regular Insulin

  • Regular insulin should be administered 30–45 minutes before meals to achieve optimal postprandial control, unlike rapid-acting analogs which are given 0–15 minutes before eating. 1
  • Never administer regular insulin at bedtime as a sole correction dose, as this markedly increases nocturnal hypoglycemia risk. 1

Alternative Formulas for Different Insulin Types

  • For rapid-acting insulin analogs (lispro, aspart, glulisine), use the 1700 or 1800 rule: ISF = 1700 ÷ TDD or 1800 ÷ TDD. 2, 3, 4
  • The 1500 rule is specific to regular (short-acting) insulin due to its different pharmacokinetic profile. 1, 2

Monitoring and Adjustment Requirements

  • Recheck glucose 1–2 hours after correction to assess response and avoid insulin stacking. 1
  • If correction doses consistently fail to bring glucose into target range, adjust the ISF (not the basal dose) by recalculating with the updated TDD. 1
  • The ISF should be recalculated periodically (every few weeks to months) as total insulin requirements change, not daily. 1

Common Pitfalls to Avoid

  • Do not "stack" correction doses by giving another correction within 3–5 hours of the previous dose, as insulin from the first dose may still be active. 1
  • Avoid using correction insulin to compensate for inadequate basal or prandial coverage; if frequent corrections are needed, the scheduled insulin doses must be increased. 1
  • Do not rely solely on correction insulin without addressing the underlying inadequacy of the basal-bolus regimen. 1

Carbohydrate Coverage vs. Correction Dose

  • The insulin-to-carbohydrate ratio (ICR) for meal coverage is calculated separately: ICR = 500 ÷ TDD for regular insulin or 450 ÷ TDD for rapid-acting analogs. 5, 6, 2, 3
  • For this patient: ICR = 500 ÷ 60 = 1 unit per 8.3 grams of carbohydrate (round to 1:8 or 1:10 for practical use). 5
  • Total mealtime insulin = carbohydrate coverage + correction dose; these are calculated independently and then summed. 5, 1

Example Calculation for Complete Mealtime Dose

  • If this patient is about to eat a meal with 60 grams of carbohydrate:
    • Carbohydrate coverage: 60 g ÷ 8 = 7.5 units (round to 8 units)
    • Correction dose: (200 – 100) ÷ 25 = 4 units
    • Total pre-meal dose: 8 + 4 = 12 units of regular insulin 5, 1

Safety Thresholds

  • Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate before considering correction insulin. 1
  • If hypoglycemia occurs after a correction dose, reduce the ISF (increase the denominator) to make future corrections less aggressive. 1

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Research

Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.